News | Treatment Planning | February 26, 2018

MD Anderson and RaySearch Partner to Advance Adaptive Radiation Therapy

Collaboration will focus on improving precise targeting of tumors through advanced imaging, other techniques to help increase adoption of adaptive radiotherapy for cancer treatment

MD Anderson and RaySearch Partner to Advance Adaptive Radiation Therapy

February 26, 2018 — The University of Texas MD Anderson Cancer Center and RaySearch Laboratories announced a new strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives. The partnership will focus on goals including more precisely targeting tumors and improving upon, and making more available, adaptive radiation therapy (ART), currently only used at highly specialized care centers.

Successful radiation therapy depends on the ability to delineate the precise tumor location. Since most radiation treatments are delivered over several weeks, a number of variables can compromise treatment accuracy. Traditionally, additional margins are set around the target area to allow for tumor movement and variations in how patients are positioned during treatment.

However, these margins do not always compensate for unexpected changes in the tumor and surrounding normal tissue over the full course of radiation treatment. ART uses frequent imaging to give an up-to-date assessment of physical changes and enable precisely tailored treatment for each patient.

The partnership — which builds upon a previously established relationship between RaySearch and MD Anderson centered on RayCare, RaySearch’s new oncology information system (OIS) — combines MD Anderson’s clinical data and expertise with the latest technology and platforms available through RaySearch and will focus on the following areas:

  • Integration of advanced imaging into the treatment planning process to help define the tumor targets better;
  • Management of changes in the tumor that may occur during treatment, and monitoring and adjusting treatment to accommodate each patient’s individual circumstances at any point during therapy; and
  • Building software components with the aim of creating a new standard of care in radiation therapy.

“The technology to perform adaptive radiation therapy has been around for a number of years and studies have demonstrated its advantages,” said Caroline Chung, M.D., assistant professor of radiation oncology at MD Anderson. “However, it is a complex process that has not yet been broadly adopted in clinical practice and is largely limited to highly specialized care centers. The goal of this collaboration is to establish a methodology and workflow, clinically tested at MD Anderson, which can be streamlined and automated to enable adaptive radiation therapy on a larger scale.”

The combination of advanced imaging data, including platforms such as RayCare and the treatment planning system RayStation, will be vital to improving the delineation of tumors. Together, this provides a novel opportunity for more personalized treatment and the development of digital workflows has the potential to improve patient care at MD Anderson and other cancer care facilities around the world.

For more information: www.raysearchlabs.com, www.mdanderson.org

Related Radiation Therapy Content

RaySearch Launches RayCare Oncology Information System

RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System

Generating Precise Treatment Plans

Treatment Planning Systems Comparison Chart (requires registration but is free)

 

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis
A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely aut
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init